QA: Bellicum Pharmaceuticals INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001358403_2021_Bellicum_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001358403, Bellicum Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 39,443,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 189,000
3 remainder_Assets 952,000
4 LiabilitiesCurrent 24,701,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 344,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,971,289
9 ResearchAndDevelopmentExpense 1,781,364
10 remainder_Expenses 0
11 remainder_Revenues 4,452,215
12 remainder_NetIncome -25,085,723
13 remainder_ComprehensiveNetIncome -12,000
  yvar yval
0 Assets 40,584,000
1 Liabilities 25,045,000
2 Expenses 14,752,653
3 Revenues 4,452,215
4 StockholdersEquity 15,539,000
5 NetIncome -35,386,161
6 ComprehensiveNetIncome -35,392,161
7 BaseVar 54,965,796
8 EconomicCapitalRatiobeforeLimitedLiability -0.0462
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time